Microarray analysis after adipose derived mesenchymal stem cells injection in monosodium iodoacetate-induced osteoarthritis rats
- PMID: 29892899
- DOI: 10.1007/s13258-017-0607-7
Microarray analysis after adipose derived mesenchymal stem cells injection in monosodium iodoacetate-induced osteoarthritis rats
Abstract
Osteoarthritis (OA) is a degenerative joint disease characterized by abrasion, and ultimately, destruction of the articular cartilage and trabecular bone loss. OA is still considered a devastating disease, which requires an aggressive therapeutic approach. Despite the therapeutic potential of human adipose-derived mesenchymal stem cells (AD-MSCs), the molecular parameters needed to define the "stemness" remain largely unknown. Using high-density oligonucleotide microarrays, the differential gene expression profiles between a fraction of human adipose-derived (AD) mononuclear cells and its MSC subpopulation were obtained. Of particular interest was a subset of 58 genes preferentially expressed at sevenfold or higher in the group treated with human AD-MSCs. This subset contained numerous genes involved in the inflammatory response, immune response, lipid metabolism, cell death, cell proliferation, and DNA repair. Additionally, four protein networks were constructed. The interaction network consisted of 46 proteins encoded by up-regulated genes. However, the interaction network also consisted of 38 proteins encoded by down-regulated genes. My results provide a basis for a more reproducible and reliable quality control using genotypic analysis for the definition of human AD-MSCs. Therefore, these results will provide a basis for studies on molecular mechanisms controlling the core properties of human MSCs.
Keywords: Adipose-derived mesenchymal stem cells; Inflammatory response; Microarray; Monosodium iodoacetate; Osteoarthritis.
Similar articles
-
Intraarticular injection of processed lipoaspirate cells has anti-inflammatory and analgesic effects but does not improve degenerative changes in murine monoiodoacetate-induced osteoarthritis.BMC Musculoskelet Disord. 2019 Jul 19;20(1):335. doi: 10.1186/s12891-019-2710-1. BMC Musculoskelet Disord. 2019. PMID: 31324245 Free PMC article.
-
The Therapeutic Effect of STAT3 Signaling-Suppressed MSC on Pain and Articular Cartilage Damage in a Rat Model of Monosodium Iodoacetate-Induced Osteoarthritis.Front Immunol. 2018 Dec 11;9:2881. doi: 10.3389/fimmu.2018.02881. eCollection 2018. Front Immunol. 2018. PMID: 30619261 Free PMC article.
-
Effect of in vitro chondrogenic differentiation of autologous mesenchymal stem cells on cartilage and subchondral cancellous bone repair in osteoarthritis of temporomandibular joint.Int J Oral Maxillofac Surg. 2013 Feb;42(2):240-8. doi: 10.1016/j.ijom.2012.05.030. Epub 2012 Jul 2. Int J Oral Maxillofac Surg. 2013. PMID: 22763137
-
Mesenchymal Stem Cells and Their Clinical Applications in Osteoarthritis.Cell Transplant. 2016;25(5):937-50. doi: 10.3727/096368915X690288. Epub 2015 Dec 18. Cell Transplant. 2016. PMID: 26688464 Review.
-
Treatment of osteoarthritis with mesenchymal stem cells.Sci China Life Sci. 2014 Jun;57(6):586-95. doi: 10.1007/s11427-014-4673-7. Epub 2014 May 21. Sci China Life Sci. 2014. PMID: 24849513 Review.
Cited by
-
Cell-based therapies have disease-modifying effects on osteoarthritis in animal models. A systematic review by the ESSKA Orthobiologic Initiative. Part 1: adipose tissue-derived cell-based injectable therapies.Knee Surg Sports Traumatol Arthrosc. 2023 Feb;31(2):641-655. doi: 10.1007/s00167-022-07063-7. Epub 2022 Sep 14. Knee Surg Sports Traumatol Arthrosc. 2023. PMID: 36104484 Free PMC article.
-
The Exposure to Osteoarthritic Synovial Fluid Enhances the Immunomodulatory Profile of Adipose Mesenchymal Stem Cell Secretome.Stem Cells Int. 2020 Jul 18;2020:4058760. doi: 10.1155/2020/4058760. eCollection 2020. Stem Cells Int. 2020. PMID: 32733572 Free PMC article.
References
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Other Literature Sources